Testosterone in Women: When to Test and the Signs of Androgen Imbalance

Testosterone in Women: When to Test and the Signs of Androgen Imbalance

Testosterone is rarely part of the conversation in routine women's health care. Most standard panels skip it entirely, and when it does appear on a lab report, patients are often told their levels are "fine" without any nuanced explanation. But testosterone is far from irrelevant in women. It plays a critical role in bone density, lean muscle mass, mood regulation, libido, cognitive sharpness, and metabolic health — and when it drifts out of range in either direction, the downstream effects are wide-ranging.

Androgen imbalance in women is more common than most people realize. Polycystic ovary syndrome (PCOS) alone affects an estimated 8–13% of women of reproductive age globally, with androgen excess being a defining diagnostic criterion for most subtypes (Bozdag et al., Human Reproduction Update 2016; PMID: 27664216). On the other end, low testosterone in women contributes to reduced sexual function, fatigue, and mood disruption — yet it remains poorly recognized and rarely treated systematically.

This article breaks down what a testosterone women blood test actually measures, how to interpret your results, and what the clinical literature says about the signs, causes, and interventions for androgen imbalance.

---

What a Testosterone Women Blood Test Actually Measures

When you order or receive a testosterone panel, you may see up to three distinct values: total testosterone, free testosterone, and SHBG (sex hormone-binding globulin). Each tells a different part of the story.

Total testosterone reflects all circulating testosterone in the blood — both bound to proteins and unbound. The reference range for women is typically reported as 15–70 ng/dL, though this varies slightly by laboratory and life stage. Postmenopausal women naturally have lower levels, often falling in the 7–40 ng/dL range.

Free testosterone is the biologically active fraction — testosterone that is not bound to SHBG or albumin and is therefore available to enter cells and exert its effects. This is often the more clinically informative number, particularly when symptoms are present but total testosterone appears normal.

SHBG modulates how much testosterone is freely available. High SHBG (common with oral contraceptive use, thyroid disease, or liver dysfunction) can suppress free testosterone even when total levels look adequate. Low SHBG — seen in insulin resistance, obesity, and hypothyroidism — can drive up free testosterone and contribute to androgen excess symptoms.

Timing of the test matters. Testosterone is highest in the morning and in the early follicular phase of the menstrual cycle (days 2–7). Testing at other times or in the luteal phase can artificially depress results. Requesting a morning draw on a cycle day 2–5 gives the most reproducible baseline.

For context on how these markers interact with other hormonal data, understanding your full hormonal lab panel is a useful starting point before interpreting any single number in isolation.

---

Free Testosterone in Women: Why the "Normal Range" Is Misleading

Free testosterone in women is measured in picograms per milliliter (pg/mL) and is typically reported in a range of 0.3–1.9 pg/mL for premenopausal women, though labs vary. The problem with these ranges is that they are derived from population statistics — not from outcomes data. Being "within range" does not mean your level is optimal for your biology, your symptoms, or your goals.

A 2019 analysis published in the Journal of Clinical Endocrinology & Metabolism highlighted significant interlaboratory variability in testosterone measurements for women, particularly at the lower end of the range, making interpretation even more challenging (Handelsman et al., JCEM 2019; PMID: 31393558). This is part of why many clinicians advocate for calculated free testosterone (derived from total testosterone, SHBG, and albumin) rather than direct immunoassay-based free testosterone measurements, which can be imprecise at low concentrations.

Symptoms of low free testosterone in women include:

• Decreased libido and sexual satisfaction
• Low energy and exercise intolerance
• Reduced muscle tone despite adequate training
• Brain fog, low motivation, and depressive symptoms
• Decreased bone density over time

Symptoms of elevated free testosterone include:

• Oily skin and cystic acne (especially along the jawline)
• Hirsutism (excess facial or body hair)
• Hair thinning or androgenic alopecia at the crown
• Irregular or absent menstrual cycles
• Clitoral enlargement in severe cases

The same total testosterone value can produce entirely different symptom profiles depending on SHBG levels, androgen receptor sensitivity, and how efficiently the body converts testosterone to DHT (dihydrotestosterone) or estrogen via aromatase.

---

Androgen Excess in Women: Causes, Mechanisms, and Clinical Significance

Androgen excess in women — also called hyperandrogenism — is defined clinically by elevated androgen levels in blood combined with signs such as hirsutism, acne, or androgenic alopecia. It is not a single diagnosis but a pattern with several distinct etiologies.

The most common causes include:

1. PCOS — accounts for approximately 70–80% of androgen excess cases in women of reproductive age
2. Congenital adrenal hyperplasia (CAH) — particularly non-classic CAH, which can mimic PCOS closely
3. Adrenal or ovarian tumors — rare, but important to rule out when testosterone levels are markedly elevated (>150 ng/dL)
4. Cushing's syndrome — excess cortisol from the adrenal glands can drive androgen production
5. Insulin resistance and metabolic syndrome — hyperinsulinemia stimulates ovarian androgen production independently of PCOS
6. Exogenous androgen exposure — including DHEA supplements, anabolic compounds, or contaminated products

Androgens in women are produced by both the ovaries (~25%) and the adrenal glands (~25%), with the remaining ~50% coming from peripheral conversion of androgen precursors like DHEA-S and androstenedione in fat tissue, skin, and muscle (Burger, Clinical Endocrinology 2002; PMID: 11849231).

This means that even without ovarian pathology, elevated body fat — particularly central adiposity — can meaningfully increase androgen activity through peripheral conversion. It also means that interventions targeting insulin sensitivity, cortisol regulation, and inflammation can have real downstream effects on androgen balance.

For women with signs of androgen excess, a comprehensive panel should include not just total and free testosterone, but also DHEA-S, androstenedione, 17-hydroxyprogesterone (to screen for CAH), fasting insulin, and SHBG. Interpreting DHEA-S and adrenal androgen markers alongside testosterone gives a much more complete picture of where excess androgens are originating.

---

PCOS Testosterone Levels: What the Numbers Tell You

PCOS is defined by the Rotterdam criteria as requiring two of three features: irregular ovulation, clinical or biochemical hyperandrogenism, and polycystic ovarian morphology on ultrasound. Biochemical hyperandrogenism — meaning elevated testosterone, free testosterone, or free androgen index on bloodwork — is present in roughly 60–80% of women with PCOS (Lizneva et al., Fertility and Sterility 2016; PMID: 27364092).

Typical testosterone patterns in PCOS include:

The suppression of SHBG in PCOS is largely driven by hyperinsulinemia. Insulin directly inhibits hepatic SHBG synthesis, meaning that even modest improvements in insulin sensitivity can raise SHBG and reduce free androgen activity without directly lowering testosterone production. This is one mechanism by which lifestyle interventions and insulin-sensitizing agents like inositol show clinical benefit in PCOS.

A 2019 meta-analysis in Advances in Nutrition found that myo-inositol supplementation (2–4g/day) significantly reduced fasting insulin, total testosterone, and improved menstrual regularity in women with PCOS across multiple randomized controlled trials (Unfer et al., Advances in Nutrition 2019; doi.org/10.1093/advances/nmz070). This positions inositol as one of the better-evidenced nutritional interventions for the androgen excess associated with PCOS.

Beyond inositol, magnesium deserves attention in this context. Magnesium deficiency is prevalent in women with PCOS and correlates with worse insulin resistance and inflammatory markers. Women with PCOS also show higher urinary magnesium excretion, creating a cycle of depletion (Asbaghi et al., European Journal of Obstetrics & Gynecology and Reproductive Biology 2022; PMID: 35248926). If you're navigating PCOS-related androgen excess, optimal magnesium glycinate dosage for hormonal health is worth understanding alongside your testosterone panel.

---

Hyperandrogenism: Clinical Evaluation and When to Seek Further Testing

Hyperandrogenism is a clinical diagnosis supported by lab evidence. The presence of symptoms alone — particularly hirsutism, acne, or alopecia — is sufficient reason to request testing, even if your previous labs were "normal." Standard immunoassay testosterone tests are notoriously imprecise in women, particularly in the lower-to-normal range. Mass spectrometry-based testing (LC-MS/MS), offered by specialized labs, provides significantly better accuracy and is increasingly recommended by the Endocrine Society for female androgen measurement (Rosner et al., JCEM 2007; PMID: 17090633).

When to request a testosterone panel:

• New or worsening acne that is cystic or jawline-predominant after age 25
• Hirsutism scoring above 8 on the modified Ferriman-Gallwey scale
• Irregular cycles (fewer than 8 cycles per year or cycles >35 days)
• Unexplained hair thinning at the crown or temples
• Diagnosis or suspected diagnosis of PCOS
• Low libido, fatigue, or mood changes not explained by thyroid or cortisol testing
• Perimenopause or surgical menopause with unexplained energy or libido decline

If total testosterone exceeds 150–200 ng/dL, imaging of the adrenal glands and ovaries is warranted to rule out androgen-secreting tumors — a rare but serious cause of hyperandrogenism.

For women investigating hormone-related fatigue and mood symptoms, clinical evidence for ashwagandha in cortisol and stress regulation is relevant, particularly because HPA axis dysregulation and elevated cortisol can worsen the adrenal contribution to androgen production.

---

What This Means for Your Formula

Androgen balance in women sits at the intersection of insulin sensitivity, cortisol regulation, liver function (which governs SHBG synthesis and hormone clearance), and nutrient status. No single supplement resolves androgen imbalance, but several ingredients have meaningful evidence when matched to the right mechanism.

Ones builds personalized formulas based on your blood work, wearable data, and health history — and several ingredients in the system are clinically relevant to female androgen balance:

Ashwagandha (KSM-66, 600mg): The adaptogenic root has demonstrated reductions in cortisol and improvements in thyroid function in clinical trials. Because elevated cortisol promotes adrenal androgen production (particularly DHEA and androstenedione), managing the HPA axis indirectly supports androgen balance. A double-blind RCT in Medicine (2019) found 600mg/day KSM-66 significantly reduced cortisol and self-reported stress compared to placebo (Salve et al., Cureus 2019; PMID: 31975480). Ones includes KSM-66 at the full 600mg clinical dose.

Magnesium Complex: Magnesium glycinate supports insulin sensitivity and reduces inflammatory signaling — both upstream drivers of ovarian androgen excess. Ones' Magnesium Complex is formulated for bioavailability, using glycinate chelate forms that are better tolerated and absorbed than oxide or citrate forms at equivalent doses.

Liver Support Blend: SHBG is synthesized in the liver, and impaired liver detoxification can disrupt the clearance of androgens from circulation. Ones' proprietary Liver Support System Blend is designed to support Phase I and Phase II hepatic detoxification pathways, which are essential for proper sex hormone metabolism. Ingredients in this category include NAC (N-acetylcysteine), which supports glutathione synthesis and has been studied specifically in PCOS for its insulin-sensitizing and antioxidant effects (Thakker et al., Reproductive BioMedicine Online 2015; PMID: 25812713).

If your blood work reveals elevated androgens, low SHBG, or insulin resistance alongside hormonal symptoms, Ones' AI health practitioner can cross-reference those markers against your full data profile to build a formula that addresses the root pattern — not just the symptom.

---

Key Takeaways

• Testosterone testing in women requires the right markers: Total testosterone alone is insufficient. Free testosterone, SHBG, DHEA-S, and fasting insulin together provide the full androgen picture.
• Free testosterone is often more clinically meaningful than total testosterone, particularly when symptoms are present but total levels appear within range.
• PCOS is the leading cause of androgen excess, affecting 8–13% of women, and is driven by a cycle of hyperinsulinemia, low SHBG, and elevated ovarian androgen production.
• Timing and test methodology matter: Morning draws, cycle day 2–5 testing, and LC-MS/MS methods improve accuracy of female testosterone measurement.
• Nutritional and adaptogenic interventions — including myo-inositol, magnesium, ashwagandha, and NAC — have clinical evidence for improving androgen balance via insulin sensitivity, HPA axis regulation, and liver detoxification.
• Always consult a qualified healthcare provider for diagnosis and treatment of androgen disorders. Personalized supplementation from platforms like Ones can support — but not replace — medical evaluation and management.